Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
-62.1K
-
Total reported value, excl. options
-
$218M
-
Value change
-
-$2.95M
-
Put/Call ratio
-
2.78
-
Number of buys
-
42
-
Number of sells
-
-33
-
Price
-
$8.01
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2016
112 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q3 2016.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 386M outstanding shares and own 7.04% of the company stock.
Largest 10 shareholders include LEVIN CAPITAL STRATEGIES, L.P. (4.39M shares), PRIMECAP MANAGEMENT CO/CA/ (4.27M shares), FRANKLIN RESOURCES INC (1.99M shares), WASATCH ADVISORS INC (1.87M shares), ORBIMED ADVISORS LLC (1.75M shares), Emerald Acquisition Ltd. (1.7M shares), Neuberger Berman Group LLC (1.26M shares), VANGUARD GROUP INC (1.13M shares), BlackRock Institutional Trust Company, N.A. (806K shares), and BlackRock Fund Advisors (806K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.